Treatment of Intracranial Infection Caused by Methicillin-Resistant Staphylococcus epidermidis with Linezolid Following Poor Outcome of Vancomycin Therapy: A Case Report and Literature Review

References

• van de Beek D, Drake JM, Tunkel AR. Nosocomial bacterial meningitis. N Engl J Med. 2010;362(2):146–154. doi:10.1056/NEJMra080457320071704
   PubMed Web of Science ®Google Scholar
• Tunkel AR, Hasbun R, Bhimraj A, et al. 2017 Infectious diseases society of america’s clinical practice guidelines for healthcare-associated ventriculitis and meningitis. Clin Infect Dis. 2017;64(6):e34–e65. doi:10.1093/cid/ciw86128203777
   PubMed Web of Science ®Google Scholar
• van de Beek D, Cabellos C, Dzupova O, et al. ESCMID guideline: diagnosis and treatment of acute bacterial meningitis. Clin Microbiol Infect. 2016;22(Suppl 3):S37–62. doi:10.1016/j.cmi.2016.01.00727062097
   PubMed Web of Science ®Google Scholar
• Rybak M, Lomaestro B, Rotschafer JC, et al. Therapeutic monitoring of vancomycin in adult patients: a consensus review of the American Society of health-system pharmacists, the infectious diseases society of America, and the society of infectious diseases pharmacists. Am J Health Syst Pharm. 2009;66(1):82–98. doi:10.2146/ajhp08043419106348
   PubMedGoogle Scholar
• He N, Su S, Ye Z, et al. Evidence-based guideline for therapeutic drug monitoring of vancomycin: 2020 update by the division of therapeutic drug monitoring, Chinese pharmacological society. Clin Infect Dis. 2020;71(Suppl 4):S363–S371. doi:10.1093/cid/ciaa153633367582
   PubMed Web of Science ®Google Scholar
• Rybak MJ, Le J, Lodise TP, et al. Therapeutic monitoring of vancomycin for serious methicillin-resistant Staphylococcus aureus infections: a revised consensus guideline and review by the American society of health-system pharmacists, the infectious diseases society of America, the pediatric infectious diseases society, and the society of infectious diseases pharmacists. Am J Health Syst Pharm. 2020;77(11):835–864. doi:10.1093/ajhp/zxaa03632191793
   PubMed Web of Science ®Google Scholar
• Beach JE, Perrott J, Turgeon RD, et al. Penetration of vancomycin into the cerebrospinal fluid: a systematic review. Clin Pharmacokinet. 2017;56(12):1479–1490. doi:10.1007/s40262-017-0548-y28528396
   PubMed Web of Science ®Google Scholar
• Yilmaz A, Dalgic N, Müslüman M, et al. Linezolid treatment of shunt-related cerebrospinal fluid infections in children. J Neurosurg Pediatr. 2010;5(5):443–448. doi:10.3171/2009.12.PEDS0942120433254
   PubMed Web of Science ®Google Scholar
• Maranich AM, Rajnik M. Successful treatment of vancomycin-resistant enterococcal ventriculitis in a pediatric patient with linezolid. Mil Med. 2008;173(9):927–929. doi:10.7205/milmed.173.9.92718816936
   PubMed Web of Science ®Google Scholar
• Graham PL, Ampofo K, Saiman L. Linezolid treatment of vancomycin-resistant Enterococcus faecium ventriculitis. Pediatr Infect Dis J. 2002;21(8):798–800. doi:10.1097/00006454-200208000-0002512233719
   PubMed Web of Science ®Google Scholar
• Di Paolo A, Gori G, Tascini C, et al. Clinical pharmacokinetics of antibacterials in cerebrospinal fluid. Clin Pharmacokinet. 2013;52(7):511–542. doi:10.1007/s40262-013-0062-923605634
   PubMed Web of Science ®Google Scholar
• Dryden MS. Linezolid pharmacokinetics and pharmacodynamics in clinical treatment. J Antimicrob Chemother. 2011;66(Suppl 4):iv7–iv15. doi:10.1093/jac/dkr07221521707
   PubMed Web of Science ®Google Scholar
• Sipahi OR, Bardak S, Turhan T, et al. Linezolid in the treatment of methicillin-resistant staphylococcal post-neurosurgical meningitis: a series of 17 cases. Scand J Infect Dis. 2011;43(10):757–764. doi:10.3109/00365548.2011.58517721671825
   PubMed Web of Science ®Google Scholar
• Andes D, van Ogtrop ML, Peng J, et al. In vivo pharmacodynamics of a new oxazolidinone (linezolid). Antimicrob Agents Chemother. 2002;46(11):3484–3489. doi:10.1128/aac.46.11.3484-3489.200212384354
   PubMed Web of Science ®Google Scholar
• Wu X, Tang Y, Zhang X, et al. Pharmacokinetics and pharmacodynamics of linezolid in plasma/cerebrospinal fluid in patients with cerebral hemorrhage after lateral ventricular drainage by Monte Carlo simulation. Drug Des Devel Ther. 2018;12:1679–1684. doi:10.2147/DDDT.S168757
   PubMed Web of Science ®Google Scholar
• Beer R, Engelhardt KW, Pfausler B, et al. Pharmacokinetics of intravenous linezolid in cerebrospinal fluid and plasma in neurointensive care patients with staphylococcal ventriculitis associated with external ventricular drains. Antimicrob Agents Chemother. 2007;51(1):379–382. doi:10.1128/AAC.00515-0617043116
   PubMed Web of Science ®Google Scholar
• Kelesidis T, Humphries R, Ward K, et al. Combination therapy with daptomycin, linezolid, and rifampin as treatment option for MRSA meningitis and bacteremia. Diagn Microbiol Infect Dis. 2011;71(3):286–290. doi:10.1016/j.diagmicrobio.2011.07.00121855248
   PubMed Web of Science ®Google Scholar
• Malacarne P, Viaggi B, Dip A, et al. Linezolid cerebrospinal fluid concentration in central nervous system infection. J Chemother. 2007;19(1):90–93. doi:10.1179/joc.2007.19.1.9017309857
   PubMed Web of Science ®Google Scholar
• De Bus L, Depuydt P, Libbrecht L, et al. Severe drug-induced liver injury associated with prolonged use of linezolid. J Med Toxicol. 2010;6(3):322–326. doi:10.1007/s13181-010-0047-020358416
   PubMedGoogle Scholar
• Auriti C, Piersigilli F, Bersani I, et al. Staphylococcal meningitis therapy with linezolid in a young infant: efficacy, CSF levels and side effects. Ital J Pediatr. 2020;46(1):90. doi:10.1186/s13052-020-00854-z32600437
   PubMed Web of Science ®Google Scholar
• Kim HS, Kim H, Jeong YJ, et al. Comparative analysis of the suspected heparin-induced thrombocytopenia level in Korea. Basic Clin Pharmacol Toxicol. 2017;121(4):360–367. doi:10.1111/bcpt.1279128374942
   PubMed Web of Science ®Google Scholar
• Vandijck DM, Blot SI, De Waele JJ, et al. Thrombocytopenia and outcome in critically ill patients with bloodstream infection. Heart Lung. 2010;39(1):21–26. doi:10.1016/j.hrtlng.2009.07.00520109983
   PubMed Web of Science ®Google Scholar
• Choi GW, Lee JY, Chang MJ, et al. Risk factors for linezolid-induced thrombocytopenia in patients without haemato-oncologic diseases. Basic Clin Pharmacol Toxicol. 2019;124(2):228–234. doi:10.1111/bcpt.1312330171804
   PubMed Web of Science ®Google Scholar
• Kino H, Suzuki H, Yamaguchi T, et al. Central nervous system infection caused by vancomycin-intermediate Staphylococcus aureus (SCCmec type IV, ST8). J Infect Chemother. 2014;20(10):643–646. doi:10.1016/j.jiac.2014.06.00825012468
   PubMed Web of Science ®Google Scholar
• Kruse AJ, Peerdeman SM, Bet PM, et al. Successful treatment with linezolid and rifampicin of meningitis due to methicillin-resistant Staphylococcus epidermidis refractory to vancomycin treatment. Eur J Clin Microbiol Infect Dis. 2006;25(2):135–137. doi:10.1007/s10096-006-0097-z16474940
   PubMed Web of Science ®Google Scholar
• Fernández-Ruiz M, Cervera C, Pitart C, et al. Community-acquired methicillin-resistant Staphylococcus aureus meningitis complicated by cerebral infarction. Role of antibiotic combination of linezolid plus levofloxacin. Intern Med. 2010;49(18):1971–1974. doi:10.2169/internalmedicine.49.394220847500
   PubMed Web of Science ®Google Scholar
• Ochi F, Tauchi H, Nagai K, et al. Therapeutic effect of linezolid in children with health care-associated meningitis or ventriculitis. Clin Pediatr (Phila). 2018;57(14):1672–1676. doi:10.1177/000992281880339930261749
   PubMed Web of Science ®Google Scholar
• Rebai L, Fitouhi N, Daghmouri MA, et al. Linezolid for the treatment of postneurosurgical infection caused by methicillin-resistant Staphylococcus. Surg Neurol Int. 2019;10:215. doi:10.25259/SNI_455_201931819809
   PubMedGoogle Scholar